Multiomic characterization and drug testing establish circulating tumor cells as an ex vivo tool for personalized medicine.
iScience
; 25(10): 105081, 2022 Oct 21.
Article
in En
| MEDLINE
| ID: mdl-36204272
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
IScience
Year:
2022
Document type:
Article
Affiliation country:
Taiwan
Country of publication:
United States